MDGL · NASDAQ · Biotechnology

Madrigal Pharmaceuticals (MDGL)

Commercializes Rezdiffra and develops combination therapies for MASH.

$518.83
After hours+0.33 (+0.06%)
At close$518.50(−0.66%)